On Tuesday 21 April, MedCap AB announced the successful completion of a directed issue of c. 1.35 million ordinary shares, raising gross proceeds of SEK 229m. On the back of strong demand from high quality investors, the transaction was upsized to nearly twice the initial amount of shares offered. The subscription price of SEK 170 was determined in an accelerated book building process and corresponds to a discount of 0.4% in relation to the 10-day value weighted average price.
The share issue was directed to a large number of Swedish and international investors, including very reputable institutions such as Aktia Asset Management, Consensus Asset Management, Creades, Fondita Fonder, ODIN Fonder, SEB Fonder and Swedbank Robur Fonder, among others. The proceeds strengthen MedCap’s readiness for continued acquisitions.
Contact